Novel sulfonamides bearing pyrrole and pyrrolopyrimidine moieties as carbonic anhydrase inhibitors: Synthesis, cytotoxic activity and molecular modeling

Loading...
Thumbnail Image

Date

2014-11

Journal Title

Journal ISSN

Volume Title

Type

Article

Publisher

Elsevier

Series Info

European Journal of Medicinal Chemistry;Volume 87, 24 November 2014, Pages 186-196

Abstract

Novel sulfonamides bearing pyrrole and pyrrolopyrimidine moieties as carbonic anhydrase inhibitors: synthesis, cytotoxic activity and molecular modeling المؤلفون Mostafa M Ghorab, Mariangela Ceruso, Mansour S Alsaid, Yassin M Nissan, Reem K Arafa, Claudiu T Supuran تاريخ النشر 2014/11/24 مجلة European journal of medicinal chemistry المجلد 87 الصفحات 186-196 الناشر Elsevier Masson الوصف Novel pyrrole and pyrrolopyrimidine scaffold-based sulfonamides were designed and synthesized. The carbonic anhydrase (CA) inhibition ability of all derivatives was assessed against the human (h) cytosolic isoforms hCA I and II and the transmembrane, tumor-associated isoforms hCA IX and XII. Some of these sulfonamides were 6–8 fold more potent than the reference drug acetazolamide (AZA, Ki = 5.7 nM)) against hCA XII showing subnanomolar activity. The in vitro cytotoxicity of these derivatives was evaluated against MCF-7, where some derivatives were more cytotoxic than doxorubicin (IC50 = 8.02 μM) displaying IC50 values between 6.46 and 7.56 μM. Docking of these sulfonamides with CA XII was performed and their binding modes were comparable with that of AZA.

Description

MSA GOOGLE SCHOLAR

Keywords

university of Cytotoxic activity, Carbonic anhydrase, Sulfonamides, Pyrrolopyrimidines, Pyrroles

Citation

Full Text link